European and African Agencies Release Joint Guidance for Bundibugyo Ebola Vaccine Trials

The European Medicines Agency (EMA) and the African Medicines Agency (AMA) have jointly published a position paper detailing clinical trial requirements for Bundibugyo Ebola virus vaccines. This guidance aims to expedite the development of effective vaccines to address the escalating multi-country outbreak, ensuring regulatory standards for safety and efficacy are met. It is crucial for accelerating global health responses to emerging threats.